Bourgeois Fabienne C, Sinha Amrita, Tuli Gaurav, Harper Marvin B, Robbins Virginia K, Jeffrey Sydney, Brownstein John S, Jilani Shahla M
Department of Pediatrics, Boston Children's Hospital, Boston, MA 02115, United States.
Harvard Medical School, Boston, MA 02115, United States.
J Am Med Inform Assoc. 2025 Mar 1;32(3):417-425. doi: 10.1093/jamia/ocae315.
Timely access to data is needed to improve care for substance-exposed birthing persons and their infants, a significant public health problem in the United States. We examined the current state of birthing person and infant/child (dyad) data-sharing capabilities supported by health information exchange (HIE) standards and HIE network capabilities for data exchange to inform point-of-care needs assessment for the substance-exposed dyad.
A cross-map analysis was performed using a set of dyadic data elements focused on pediatric development and longitudinal supportive care for substance-exposed dyads (70 birthing person and 110 infant/child elements). Cross-mapping was conducted to identify definitional alignment to standardized data fields within national healthcare data exchange standards, the United States Core Data for Interoperability (USCDI) version 4 (v4) and Fast Healthcare Interoperability Resources (FHIR) release 4 (R4), and applicable structured vocabulary standards or terminology associated with USCDI. Subsequent survey analysis examined representative HIE network sharing capabilities, focusing on USCDI and FHIR usage.
91.11% of dyadic data elements cross-mapped to at least 1 USCDI v4 standardized data field (87.80% of those structured) and 88.89% to FHIR R4. 75% of the surveyed HIE networks reported supporting USCDI versions 1 or 2 and the capability to use FHIR, though demand is limited.
HIE of clinical and supportive care data for substance-exposed dyads is supported by current national standards, though limitations exist.
These findings offer a dyadic-focused framework for electronic health record-centered data exchange to inform bedside care longitudinally across clinical touchpoints and population-level health.
及时获取数据对于改善对药物暴露产妇及其婴儿的护理至关重要,这在美国是一个重大的公共卫生问题。我们研究了由健康信息交换(HIE)标准支持的产妇与婴儿/儿童(二元组)数据共享能力的现状,以及用于数据交换的HIE网络能力,以为药物暴露二元组的护理点需求评估提供信息。
使用一组关注药物暴露二元组的儿科发育和纵向支持性护理的二元数据元素(70个产妇元素和110个婴儿/儿童元素)进行交叉映射分析。进行交叉映射以确定与国家医疗数据交换标准(美国互操作性核心数据(USCDI)第4版(v4)和快速医疗互操作性资源(FHIR)第4版(R4))内的标准化数据字段的定义一致性,以及与USCDI相关的适用结构化词汇标准或术语。随后的调查分析检查了代表性的HIE网络共享能力,重点是USCDI和FHIR的使用情况。
91.11%的二元数据元素交叉映射到至少1个USCDI v4标准化数据字段(其中87.80%为结构化字段),88.89%交叉映射到FHIR R4。75%的受调查HIE网络报告支持USCDI第1版或第2版以及使用FHIR的能力,不过需求有限。
当前国家标准支持药物暴露二元组的临床和支持性护理数据的HIE,尽管存在局限性。
这些发现提供了一个以二元组为重点的框架,用于以电子健康记录为中心的数据交换,以在临床接触点和人群水平健康方面纵向为床边护理提供信息。